The real world safety profile of ibrutinib in relapsed/refractory CLL/SLL patients in Japan

Hiroaki Fujimori

Presentation information

Poster Session

Fri.Oct,11

Poster Session 1-14 CLL

Fri. Oct 11, 2019 5:40 PM - 6:20 PM Poster (Tokyo International Forum, B2F Hall E)

Chair: Jun Takizawa (Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine)

[PS1-14-3] The real world safety profile of ibrutinib in relapsed/refractory CLL/SLL patients in Japan

Hiroaki Fujimori¹, Hiroaki Kinoshita², Fumi Nomura², Yasuhiko Miyata¹, Akiko Fujino², Kentaro Enjo¹ (1.Medical Affairs, Janssen Pharmaceutical KK, 2.Safety and Surveillance Division, Janssen Pharmaceutical KK)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.